Estimation of forced vital capacity using speech acoustics in patients with ALS

Abstract

In this study, we present and provide validation data for a tool that predicts forced vital capacity (FVC) from speech acoustics collected remotely via a mobile app without the need for any additional equipment (e.g. a spirometer). We trained a machine learning model on a sample of healthy participants and participants with amyotrophic lateral sclerosis (ALS) to learn a mapping from speech acoustics to FVC and used this model to predict FVC values in a new sample from a different study of participants with ALS. We further evaluated the cross-sectional accuracy of the model and its sensitivity to within-subject change in FVC. We found that the predicted and observed FVC values in the test sample had a correlation coefficient of .80 and mean absolute error between .54 L and .58 L (18.5% to 19.5%). In addition, we found that the model was able to detect longitudinal decline in FVC in the test sample, although to a lesser extent than the observed FVC values measured using a spirometer, and was highly repeatable (ICC = 0.92–0.94), although to a lesser extent than the actual FVC (ICC = .97). These results suggest that sustained phonation may be a useful surrogate for VC in both research and clinical environments.

Keywords:

• Clinical trial
• respiratory function
• speech analysis
• biomarker
• ventilation

Additional information

Funding

This work was supported by NIH SBIR [1R43DC017625-01], NSF SBIR [1853247], NIH R01 [5R01DC006859-13], ALS Finding a Cure Grant, and a grant from the Dignity Health ASU Research Collaboration.